- Home
- DASH vs BMY Comparison
DASH vs BMY Comparison
Compare DASH & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DASH
- BMY
- Stock Information
- Founded
- DASH 2013
- BMY 1887
- Country
- DASH United States
- BMY United States
- Employees
- DASH N/A
- BMY N/A
- Industry
- DASH Industrial Machinery/Components
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- DASH Industrials
- BMY Health Care
- Exchange
- DASH Nasdaq
- BMY Nasdaq
- Market Cap
- DASH 92.2B
- BMY 97.6B
- IPO Year
- DASH 2020
- BMY N/A
- Fundamental
- Price
- DASH $237.83
- BMY $47.49
- Analyst Decision
- DASH Buy
- BMY Hold
- Analyst Count
- DASH 33
- BMY 16
- Target Price
- DASH $221.22
- BMY $58.33
- AVG Volume (30 Days)
- DASH 4.3M
- BMY 14.4M
- Earning Date
- DASH 08-06-2025
- BMY 07-31-2025
- Dividend Yield
- DASH N/A
- BMY 5.22%
- EPS Growth
- DASH N/A
- BMY N/A
- EPS
- DASH 0.77
- BMY 2.67
- Revenue
- DASH $11,241,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- DASH $22.16
- BMY N/A
- Revenue Next Year
- DASH $18.73
- BMY N/A
- P/E Ratio
- DASH $297.68
- BMY $17.79
- Revenue Growth
- DASH 23.35
- BMY 4.62
- 52 Week Low
- DASH $99.32
- BMY $39.35
- 52 Week High
- DASH $248.74
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- DASH 77.63
- BMY 39.49
- Support Level
- DASH $214.94
- BMY $46.32
- Resistance Level
- DASH $223.29
- BMY $47.07
- Average True Range (ATR)
- DASH 5.72
- BMY 0.79
- MACD
- DASH 1.98
- BMY -0.16
- Stochastic Oscillator
- DASH 98.76
- BMY 6.21
About DASH DoorDash Inc.
Founded in 2013 and headquartered in San Francisco, DoorDash is an online delivery demand aggregator. Consumers can use its app to order food items on-demand for delivery or in-store from merchants. Through the acquisition of Wolt in 2022, the firm also provides this service in Europe and Asia. DoorDash creates a marketplace for merchants to establish a presence online, market their offerings, and meet demand through delivery. The firm provides similar service to nonrestaurant businesses, such as grocery, retail, and pet supplies. Dash is also rolling out nascent technology like drone delivery in an effort to continually innovate and provide the best possible service to supply-side and demand-side contingents of its marketplace.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.